There are now more than 5,000 cybersecurity vendors competing for CISO attention...
Read More ➜Noir Dove - Revenue Clarity Consulting for B2B Founders
Revenue Exists.
Scaling Does Not.
The gap is almost always between your teams, not between you and the market.
For B2B founders at $1M ARR and above. Marketing, sales, and product are operating without a shared understanding of who they are selling to and why those buyers buy. We find the specific point where that breaks down, build the strategy to fix it, and align your team to run it.
Leaderships we have worked with
Past $1M ARR, Founders Become the Only People Holding their Commercial System Together
Founders walk in thinking the problem is execution. It is almost always the structure.
Marketing runs campaigns. Sales works leads. Product ships features. Pipeline stays flat. The founder spends 15 to 20 hours a week translating between teams, sitting in deals the sales team should be closing, and explaining the product in ways no one else can yet replicate.
MARKETING
Generates leads sales cannot close
MQLs that miss the decision-maker entirely. Marketing optimises for the ICP it was given in year one. Sales is pitching to a different buyer. Neither team has noticed.
SALES
Closes on promises product has not shipped
Reps win deals by committing to roadmap features. Customers churn at month six when the product does not match the pitch. The renewal conversation never had a chance.
PRODUCT
Builds for the customer who complains, not the one who expands
Enterprise customers with the most Slack threads set the roadmap. The buyers who would pay more and refer others never get a seat at the table.
FOUNDER
Still in every important deal at $3M ARR
The team cannot close without the founder in the room. Every quarter of this costs a month of product time, fundraising bandwidth, or the next key hire.
Noir Dove is a Revenue Consulting Firm.
Our Every Engagement Starts with Diagnosis.
We work with B2B founders at $1M ARR and above whose growth has decelerated and who have already tried the obvious fixes. Content agency, new sales hire, product pivot. None of it compounded. We go into your pipeline, your team conversations, your CRM, & your customer calls. We find the specific point where your commercial motion is breaking and build the strategy your team runs for the next twelve months.
Diagnosis before strategy
Without a diagnosis, strategy is a guess. We have seen founders spend $200K on positioning work built on the wrong ICP. We run the diagnostic first.
Strategy before execution
Running campaigns before the strategy is confirmed burns $5K to $15K a month on the wrong audience. We confirm the strategy first.
Alignment before growth
Sales and marketing operating on different ICP definitions is the most common reason pipeline stays flat despite headcount growth. We align the functions before scaling anything.
Execution in the right sequence
We help with execution. Only after diagnosis, strategy, and alignment are confirmed. If a founder asks us to run campaigns before that, we decline.
The sequence is not optional. Each step depends on the one before it.
B2B Founders' Core Challenges
Founders walk in with a theory. Half the time, it is wrong.
Our experts thrive on a potent blend of cutting-edge technology, scientific precision, data insights, and a healthy dose of good old-fashioned hard work. This fusion empowers us to craft and deliver email marketing campaigns that truly resonate, engage, and drive remarkable results for our clients. Noir Dove email marketing agency is a science lab for your innovative campaigns.
ICP THAT DRIFTED AFTER LAUNCH
The product evolved. The buyer definition did not. Marketing and sales are still targeting year-one customers while the best buyers in year three look completely different. The drift goes unnoticed until churn arrives at month 12.
ICP · BUYING FRICTION
MQLs SALES DOES NOT RECOGNISE
Marketing hits its lead targets every quarter. Sales says the leads are wrong. Both are correct. Marketing is optimising for a buyer that sales has moved away from.
CROSS-FUNCTIONAL ALIGNMENT
DEALS CLOSED ON ROADMAP PROMISES
Sales closes by promising features not yet built. Churn arrives at month six when the product does not match the pitch. The renewal conversation was already lost at the close.
PIPELINE · REVENUE INTEGRITY
POSITIONING THAT MISSES THE BUYER
The narrative lands with practitioners. The CISO, the CTO, or the economic buyer who signs the contract needs a different conversation and is not getting it.
POSITIONING · MESSAGING
CHURN PRODUCT CANNOT EXPLAIN
Customers leave at month 6 or 12. Product attributes it to gaps in the roadmap. In most cases the gap was in the sale: the buyer was sold a future the product was not ready to deliver.
CONVERSION SIGNAL ANALYSIS
FOUNDER STILL CLOSING EVERY DEAL
The sales team has been hired and ramped. Every deal above $20K still needs the founder in the room. The team cannot replicate the pitch because the pitch was never written down.
COMMERCIAL SCALABILITY
ROADMAP DISCONNECTED FROM REVENUE
The loudest enterprise customer sets the quarterly roadmap. The buyers who would expand ARR and refer peers never have a seat at the planning table.
COMMERCIAL SCALABILITY
LONG SALES CYCLES WITH NO SIGNAL
Deals take 6 to 18 months. The team cannot tell which ones are real and which are polite stalls. Forecasting is a guess. Pipeline coverage means nothing.
CONVERSION SIGNAL ANALYSIS
MARKET DIVERSIFICATION NOT WORKING
Strong traction in home market. Most global enterprise buyers need proof formats, reference structures, and entry narratives that differ from every other market.
ICP DEPTH · MARKET NARRATIVE
We Have Fixed this Breakdown for
SaaS, Cybersecurity, Healthtech, and AI Founders.
B2B SaaS, cybersecurity, healthtech, and AI companies stall for the same underlying reason: the commercial motion was never formally built. The first $1M to $3M came from founder relationships and product fit. Scaling past it requires something that was never designed.
CYBERSECURITY SAAS & MSSPS
CISOs get 200+ pitches a year. Most vendors sound identical.
Procurement involves legal, IT, and the board. Each layer needs a different conversation. Technical founders build one narrative for everyone and wonder why deals stall in procurement.
B2B SAAS
The ICP that closed the first $1M is rarely the right buyer at $3M.
Most teams do not notice the drift until churn arrives at month 12. By then, marketing has built an audience around the wrong persona and sales has optimised its pitch for the wrong pain.
HEALTHTECH & DIGITAL HEALTH
Clinical & administrative buyers are different. Most pitches treat them as one.
A founder who built for the clinical buyer pitches to the procurement director. The procurement director forwards it to legal. Nothing moves. The founder thinks the product is the problem.
AI-NATIVE & AI-ENABLED FIRMS
Buyers are skeptical of AI capability claims. AI founders struggle.
Decision-makers have been burned by demos that did not reflect production reality. Narratives built around what the model can do lose to narratives built around what the buyer’s team will be able to do differently.
What We Promise (Solutions We Deliver)
4-6
Weeks starting engagement
7
Commercial dimensions examined
4
Documents every client receives
2
Founders in every engagement
50+
Countries worth of growth patterns experienced
"You'll have a unified team, a clear GTM plan, and a predictable engine for long-term growth."
- Gaurav Sabharwal
Founder and CEO, Joy of Performing (JOP)
CEO, B2B SaaS | $2.1M ARR
"We had been calling it a product problem for two years. It was a positioning problem."
Founder, Sales Tech | $3.4M ARR
"Our ICP had drifted and nobody had named it. The root cause map was the document we needed eighteen months earlier."
Co-Founder, Fintech SaaS | $1.9M ARR
"The Diagnostic found the gap between what we thought we sold and what our sales team actually pitched."
Client names withheld by mutual agreement. Sector and ARR range confirmed. References available on request.
Two founders.
One way of working.
Both founders are in every engagement. The diagnostic is not delegated to an inexperienced professional. Sakshi and Jagsir review every application personally before the engagement starts.
Sakshi is direct and structured. Founders who work with her leave knowing exactly what is broken, why it developed, and what has to change first. She makes the diagnosis actionable. Every recommendation comes with a sequence and a reason for the sequence.
Jagsir creates the conditions where founders tell the truth about their business. Real commercial problems surface only when founders feel safe enough to name them. Every recommendation he brings stays grounded in what the team can carry forward without external support.
Tech at the Core
Deep tech insights and scalable agentic automation.
Outcome-Obsessed
Every initiative ties directly to revenue or growth velocity.
Proven Track
Built GTM engines from zero, delivered compounding growth.
Trusted Partner
Dedicated growth experts guide the AI quarterly.
Read How Our Experts Think
Featured Insight
Frequently Asked Questions (FAQs)
Are you a marketing agency?
No. We do not run campaigns, manage ad spend, or produce content on retainer. We diagnose why your commercial system, the connection between marketing, sales, and product, is not producing predictable pipeline, then build the strategy your team runs. Execution, if the findings call for it, is scoped separately.
What does skipping the diagnosis actually cost?
We have seen founders spend $200K on positioning work built on the wrong ICP, and burn $5K to $15K a month running campaigns before the strategy was confirmed. Diagnosis first is not a philosophy. It is what avoids that spend.
We already have a marketing and sales team. How would this work with them?
We do not replace your team or take over execution. The Diagnostic examines how marketing, sales, and product are currently working together. The Strategy phase gives your existing team a playbook to run. The Alignment workshop makes sure every function leaves with the same definition of who you sell to and why.
What if the Diagnostic finds something different from what we expected?
That is the most common outcome. Founders usually walk in believing the problem is positioning, or a broken funnel, or the sales team. The root cause is often somewhere else, most often in how marketing and sales have quietly drifted onto different definitions of the buyer. We show you the evidence, not just the conclusion.
How long does the engagement take?
Diagnosis runs 4 to 6 weeks. Strategy runs 2 to 3 weeks after that. Alignment is a structured workshop once the playbook is built. Most founders have a completed playbook 8 to 10 weeks from kickoff.
Do you help with execution after the Diagnostic and Strategy?
Only where the findings call for it, and only after Diagnosis, Strategy, and Alignment are confirmed. We guide, train, or manage execution through vetted partners. Many founders run execution with their own team using the playbook alone.
Who actually runs the Diagnostic?
Both founders, Sakshi Dhiman and Jagsir Singh, are in every engagement. It is not delegated to a junior analyst. Every application is reviewed by them personally before an engagement starts.
Growth does not Compound When the Structure Underneath it is Broken.
A structured diagnosis finds it. A revenue strategy fixes it. The first clarity conversation costs nothing.